NEW YORK, March 16, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of HeartWare International, Inc. (“HeartWare”) (NASDAQ:HTWR) between June 10, 2014 and January 11, 2016.
You are hereby notified that a securities class action has been commenced in the USDC for the Southern District of New York. If you purchased or otherwise acquired HeartWare securities between June 10, 2014 and January 11, 2016, your rights may be affected by this action. To get more information go to: http://zlk.9nl.com/heartware.
The complaint alleges that during the Class Period, HeartWare and certain of its senior executives made false and misleading statements and omitted material information. In particular, it is alleged that after the U.S. Food and Drug Administration issued a Warning Letter identifying numerous manufacturing and other regulatory failures at the Company’s sole manufacturing facility, Defendants falsely assured investors that the Company had addressed those problems, and that these concerns therefore posed no risk to the clinical trials or timely approval of MVAD, a pump that HeartWare is developing.
Following a series of disclosures regarding adverse effects in certain clinical trial patients, shares of HeartWare have declined from a close of $87.73 per share on June 25, 2014, to a close of just $34.50 per share on January 22, 2016.
If you suffered a loss in HeartWare you have until March 22, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/heartware.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
Meta Expands AI Training With Employee Activity Tracking Tools
John Ternus Signals Apple’s Future with Product-First AI Strategy
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 



